Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus

Journal of Virological Methods

Volumn 217, Issue , 2015, Pages 79-86

  Kati, Semra ^a,d   Hage, Elias ^a,d   Mynarek, Martin ^b   Ganzenmueller, Tina ^a,d   Indenbirken, Daniela ^c   Grundhoff, Adam ^c   Schulz, Thomas F ^a,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

BrK.219; High titre virus stocks; Human herpesvirus 8; Kaposi's sarcoma; Kaposi's sarcoma associated herpesvirus; KSHV

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN CROSS LINKING; SUSPENSION CELL CULTURE; VIROGENESIS; VIRUS CULTURE; VIRUS ENTRY; VIRUS GENOME; VIRUS LATENCY; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS REPLICATION; B LYMPHOCYTE; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; PROCEDURES; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

B-LYMPHOCYTES; CELL LINE; HERPESVIRUS 8, HUMAN; HUMANS; VIRAL LOAD; VIRUS CULTIVATION;

EID: 84924940644     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.02.022     Document Type: Article

References (35)

1. Arvanitakis L., Mesri E.A., Nador R.G., Said J.W., Asch A.S., Knowles D.M., Cesarman E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996, 88:2648-2654.
2. Bechtel J.T., Liang Y., Hvidding J., Ganem D. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 2003, 77:6474-6481.
3. Brulois K.F., Chang H., Lee A.S., Ensser A., Wong L.Y., Toth Z., Lee S.H., Lee H.R., Myoung J., Ganem D., Oh T.K., Kim J.F., Gao S.J., Jung J.U. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J. Virol. 2012, 86:9708-9720.
4. Cannon J.S., Ciufo D., Hawkins A.L., Griffin C.A., Borowitz M.J., Hayward G.S., Ambinder R.F. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J. Virol. 2000, 74:10187-10193.
5. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332:1186-1191.
6. Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86:2708-2714.
7. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
8. Ciufo D.M., Cannon J.S., Poole L.J., Wu F.Y., Murray P., Ambinder R.F., Hayward G.S. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J. Virol. 2001, 75:5614-5626.
9. Dedicoat M., Newton R., Alkharsah K.R., Sheldon J., Szabados I., Ndlovu B., Page T., Casabonne D., Gilks C.F., Cassol S.A., Whitby D., Schulz T.F. Mother-to-child transmission of human herpesvirus-8 in South Africa. J. Infect. Dis. 2004, 190:1068-1075.
10. Dohner K., Radtke K., Schmidt S., Sodeik B. Eclipse phase of herpes simplex virus type 1 infection: efficient dynein-mediated capsid transport without the small capsid protein VP26. J. Virol. 2006, 80:8211-8224.
11. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:3734-3737.
12. Ensoli B., Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 1998, 9:63-83.
13. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 2006, 1:273-296.
14. Gao S.J., Deng J.H., Zhou F.C. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J. Virol. 2003, 77:9738-9749.
15. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
16. Kati S., Tsao E.H., Gunther T., Weidner-Glunde M., Rothamel T., Grundhoff A., Kellam P., Schulz T.F. Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. J. Virol. 2013, 87:8004-8016.
17. Lagunoff M., Bechtel J., Venetsanakos E., Roy A.M., Abbey N., Herndier B., McMahon M., Ganem D. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 2002, 76:2440-2448.
18. Luka J., Kallin B., Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 1979, 94:228-231.
19. Lukac D.M., Kirshner J.R., Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 1999, 73:9348-9361.
20. May T., Butueva M., Bantner S., Markusic D., Seppen J., MacLeod R.A., Weich H., Hauser H., Wirth D. Synthetic gene regulation circuits for control of cell expansion. Tissue Eng. Part A 2010, 16:441-452.
21. Menezes J., Leibold W., Klein G., Clements G. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 1975, 22:276-284.
22. Morand P., Buisson M., Collandre H., Chanzy B., Genoulaz O., Bourgeat M.J., Pinel N., Leclercq P., Leroux D., Marechal V., Fritsch L., Ruigrok R., Seigneurin J.M. Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. Leuk. Lymphoma 1999, 35:379-387.
23. Myoung J., Ganem D. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J. Clin. Invest. 2011, 121:1130-1140.
24. Myoung J., Ganem D. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 2011, 174:12-21.
25. Myoung J., Ganem D. Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus. J. Virol. 2011, 85:9767-9777.
26. Myoung J., Ganem D. Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. Virology 2011, 413:1-11.
27. O'Connor C.M., Kedes D.H. Rhesus monkey rhadinovirus: a model for the study of KSHV. Curr. Top. Microbiol. Immunol. 2007, 312:43-69.
28. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 1996, 2:342-346.
29. Shaw R.N., Arbiser J.L., Offermann M.K. Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. Aids 2000, 14:899-902.
30. Simizu B., Rhim J.S., Wiebenga N.H., Simizu B., Rhim J.S., Wiebenga N.H. Characterization of the Tacaribe group of arboviruses, I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero). Proc. Soc. Exp. Biol. Med. 1967, 125:119-123.
31. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M.F., Clauvel J.P., Raphael M., Degos L., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
32. Vieira J., O'Hearn P.M. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 2004, 325:225-240.
33. Wandinger K., Jabs W., Siekhaus A., Bubel S., Trillenberg P., Wagner H., Wessel K., Kirchner H., Hennig H. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000, 55:178-184.
34. Zhou F.C., Zhang Y.J., Deng J.H., Wang X.P., Pan H.Y., Hettler E., Gao S.J. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 2002, 76:6185-6196.
35. zur Hausen H., O'Neill F.J., Freese U.K., Hecker E. Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 1978, 272:373-375.